Haag-Streit announces appointment of Thomas Lenzen as new CEO
Thomas Lenzen looks forward to driving the Haag-Streit Group strategy with energy, innovation, and passion
Haag-Streit is pleased to announce the appointment of Thomas Lenzen as Chief Executive Officer (CEO) of the Haag-Streit Group, effective September 1, 2025.
With more than two decades of international leadership experience in the med tech industry, Thomas Lenzen brings deep expertise in ophthalmology and a proven track record of driving business growth. He previously held senior leadership roles at Bausch + Lomb, where he led the Business Unit Surgical for DACH and later served as General Manager for the DACH region. Most recently, he was Vice President International at Haemonetics, overseeing the company’s international operations for the business unit plasma and blood center.
Commenting on his appointment, Thomas Lenzen said: “Haag-Streit has a remarkable history of shaping ophthalmology through pioneering solutions and a strong commitment to precision and quality. I am honored to lead the company into its next phase of growth. Together with my new colleagues around the world, I look forward to building on the strength of the current portfolio and driving our strategy forward with energy, innovation, and passion.”
Thomas Lenzen succeeds Thomas Bernhard, who has led Haag-Streit as CEO since 2021. During his tenure, the company launched the METIS 900 ophthalmic microscope system and prepared the upcoming introductions of the Elara 900 slit lamp and the Refractor 900 phoropter, while further integrating the Group under “One Haag-Streit” and positioning the company for sustainable international growth.
Thomas Bernhard said: “It has been a privilege to serve Haag-Streit for more than a decade, and I am proud of what we have achieved together as “One Haag-Streit.” Our groundbreaking innovations, including the Eyestar 900, METIS 900, Elara 900, and Refractor 900, alongside the transformation of individual companies into a cohesive and strategically unified organization, have laid a powerful foundation for future growth. I warmly welcome Thomas Lenzen as my successor and wish him every success in this exciting role.”
Haag-Streit expresses gratitude to Thomas Bernhard for his long-standing commitment and valuable contributions to the Group. His leadership has guided the company through significant strategic milestones, and the Group wishes him the best in his future endeavors.